Aconiti Lateralis Radix Praeparata as Potential Anticancer Herb: Bioactive Compounds and Molecular Mechanisms

被引:17
作者
Zhang, Wen [1 ,2 ]
Lu, Chaoying [1 ,2 ]
Cai, Shuhui [1 ,2 ]
Feng, Yaru [1 ,2 ]
Shan, Jinjun [3 ]
Di, Liuqing [1 ,2 ]
机构
[1] Nanjing Univ Chinese Med, Sch Pharm, Nanjing, Peoples R China
[2] Jiangsu Engn Res Ctr Efficient Delivery Syst TCM, Nanjing, Peoples R China
[3] Nanjing Univ Chinese Med, Inst Pediat, Jiangsu Key Lab Pediat Resp Dis, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
Aconiti Lateralis Radix Praeparata; Fuzi; alkaloid; polysaccharide; anticancer; mechanism; NF-KAPPA-B; DITERPENOID ALKALOIDS; BCL-2; FAMILY; CELL-DEATH; MATRIX-METALLOPROTEINASES; MITOCHONDRIAL METABOLISM; MYELOID-LEUKEMIA; CANCER; APOPTOSIS; AUTOPHAGY;
D O I
10.3389/fphar.2022.870282
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aconiti Lateralis Radix Praeparata (Fuzi in Chinese) is a traditional herbal medicine widely used in China and other Asian countries. In clinical practice, it is often used to treat heart failure, rheumatoid arthritis, and different kinds of pains. Fuzi extract and its active ingredients exert considerable anticancer, anti-inflammatory, and analgesic effects. The main chemical substances of Fuzi include alkaloids, polysaccharides, flavonoids, fatty acids, and sterols. Among of them, alkaloids and polysaccharides are responsible for the anticancer efficacy. Most bioactive alkaloids in Fuzi possess C-19 diterpenoid mother nucleus and these natural products show great potential for cancer therapy. Moreover, polysaccharides exert extraordinary tumor-suppressive functions. This review comprehensively summarized the active ingredients, antineoplastic effects, and molecular mechanisms of Fuzi by searching PubMed, Web of Science, ScienceDirect, and CNKI. The anticancer effects are largely attributed to inducing apoptosis and autophagy, inhibiting proliferation, migration and invasion, regulating body immunity, affecting energy metabolism, as well as reversing multidrug resistance. Meanwhile, several signaling pathways and biological processes are mainly involved, such as NF-kappa B, EMT, HIF-1, p38 MAPK, PI3K/AKT/mTOR, and TCA cycle. Collectively, alkaloids and polysaccharides in Fuzi might serve as attractive therapeutic candidates for the development of anticancer drugs. This review would lay a foundation and provide a basis for further basic research and clinical application of Fuzi.
引用
收藏
页数:16
相关论文
共 134 条
  • [1] Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy
    Abdel-Wahab, Ali F.
    Mahmoud, Waheed
    Al-Harizy, Randa M.
    [J]. PHARMACOLOGICAL RESEARCH, 2019, 150
  • [2] Matrix Metalloproteinases: A challenging paradigm of cancer management
    Alaseem, Ali
    Alhazzani, Khalid
    Dondapati, Priya
    Alobid, Saad
    Bishayee, Anupam
    Rathinavelu, Appu
    [J]. SEMINARS IN CANCER BIOLOGY, 2019, 56 : 100 - 115
  • [3] Recent insights into the function of autophagy in cancer
    Amaravadi, Ravi
    Kimmelman, Alec C.
    White, Eileen
    [J]. GENES & DEVELOPMENT, 2016, 30 (17) : 1913 - 1930
  • [4] Targeting Autophagy in Cancer: Recent Advances and Future Directions
    Amaravadi, Ravi K.
    Kimmelman, Alec C.
    Debnath, Jayanta
    [J]. CANCER DISCOVERY, 2019, 9 (09) : 1167 - 1181
  • [5] [安祯祥 An Zhenxiang], 2019, [中国实验方剂学杂志, Chinese Journal of Experimental Traditional Medical Formulae], V25, P79
  • [6] 刘雪强, 2004, [中国中医基础医学杂志, Chinese Journal of Basic Medicine in Traditional Chinese Medicine], V10, P55
  • [7] Regulated Cell Death: Signaling and Mechanisms
    Ashkenazi, Avi
    Salvesen, Guy
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30, 2014, 30 : 337 - 356
  • [8] Bid: a Bax-like BH3 protein
    Billen, L. P.
    Shamas-Din, A.
    Andrews, D. W.
    [J]. ONCOGENE, 2008, 27 (Suppl 1) : S93 - S104
  • [9] CD4+ T cell help in cancer immunology and immunotherapy
    Borst, Jannie
    Ahrends, Tomasz
    Babala, Nikolina
    Melief, Cornelis J. M.
    Kastenmueller, Wolfgang
    [J]. NATURE REVIEWS IMMUNOLOGY, 2018, 18 (10) : 635 - 647
  • [10] Metastasis of human colon cancer is altered by modifying expression of the β-galactoside-binding protein galectin 3
    Bresalier, RS
    Mazurek, N
    Sternberg, LR
    Byrd, JC
    Yunker, CK
    Nangia-Makker, P
    Raz, A
    [J]. GASTROENTEROLOGY, 1998, 115 (02) : 287 - 296